ONCOGENEX PHARMACEUTICALS, INC. 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Jul 8, 2010
Insider Transaction Report
Form 4
MARTINO MICHAEL A
Director
Transactions
- Exercise/Conversion
Common Stock
2010-07-06$7.25/sh+2,557$18,538→ 13,557 total - Sale
Common Stock
2010-07-06$13.02/sh−2,557$33,292→ 11,000 total - Exercise/Conversion
Stock option (right to buy)
2010-07-06−2,557→ 0 totalExercise: $7.25From: 2009-05-12Exp: 2016-05-12→ Common Stock (2,557 underlying)